Skip to main content
Clinical Trials/JPRN-UMIN000004074
JPRN-UMIN000004074Not yet recruiting未知

A study on recombinant thrombomodulin alfa in patients with disseminated intravascular coagulation (DIC) caused by sepsis receiving continuous hemodiafiltration (CHDF). - A study on recombinant thrombomodulin for septic DIC patients receiving CHDF.

Chiba University Graduate School of Medicine0 sites20 target enrollmentStarted: September 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Chronic kidney disease 2. Patients showing intracranial, pulmonary or gastrointestinal hemorrhage. 3. Patients with a history of hypersensitivity to rTM. 4. Pregnant women, nursing mothers or possibly pregnant women. 5. Other patients judged to be inappropriate at the discretion of investigators.

Investigators

Sponsor
Chiba University Graduate School of Medicine

Similar Trials